Filing Details
- Accession Number:
- 0001245261-10-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-19 13:00:00
- Reporting Period:
- 2010-04-16
- Filing Date:
- 2010-04-19
- Accepted Time:
- 2010-04-19 18:47:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069530 | Pain Therapeutics Inc | PTIE | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1252240 | Grant Schoenhard | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-16 | 1,500 | $4.40 | 49,687 | No | 4 | X | Direct | |
Common Stock | Acquisiton | 2010-04-16 | 25,000 | $5.25 | 74,687 | No | 4 | X | Direct | |
Common Stock | Disposition | 2010-04-16 | 26,500 | $6.29 | 48,187 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock | Disposition | 2010-04-16 | 1,500 | $4.40 | 1,500 | $4.40 |
Common Stock | Common Stock | Disposition | 2010-04-16 | 25,000 | $5.25 | 25,000 | $5.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
708,500 | 2009-12-31 | 2019-07-31 | No | 4 | X | Direct |
683,500 | 2009-05-31 | 2015-05-31 | No | 4 | X | Direct |
Footnotes
- This sale is made pursuant to a plan intended to comply with rule 10b5-1(c). 26,500 shares of common stock were sold in twenty-three (23) lots at prices ranging from $6.235 to $6.49 per share.